Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Koninklijke DSM NV's DSM Pharmaceutical Products Signs Master Supply Agreement With Eisai Co Ltd's Eisai Inc


Tuesday, 5 Mar 2013 02:00am EST 

Koninklijke DSM NV's DSM Pharmaceutical Products, the custom manufacturing and technology business announced the signing of a three year master supply agreement with Eisai Inc., based in Woodcliff Lake, NJ, USA, for the production of sterile products. The agreement covers the production of eribulin mesylate as well as other developmental drugs. DSM will be a supplier for eribulin mesylate to the US market. Commercial production is anticipated to start in early 2013. No financial details were disclosed. 

Related Company News

Company Quote

4229.5
13.5 +0.32%
2:00am EDT